287 related articles for article (PubMed ID: 18774340)
21. Coagulation factor Xa induces an inflammatory signalling by activation of protease-activated receptors in human atrial tissue.
Bukowska A; Zacharias I; Weinert S; Skopp K; Hartmann C; Huth C; Goette A
Eur J Pharmacol; 2013 Oct; 718(1-3):114-23. PubMed ID: 24041930
[TBL] [Abstract][Full Text] [Related]
22. Signaling of the tissue factor coagulation pathway in angiogenesis and cancer.
Belting M; Ahamed J; Ruf W
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1545-50. PubMed ID: 15905465
[TBL] [Abstract][Full Text] [Related]
23. Thrombin signaling in the brain: the role of protease-activated receptors.
Wang H; Reiser G
Biol Chem; 2003 Feb; 384(2):193-202. PubMed ID: 12675511
[TBL] [Abstract][Full Text] [Related]
24. Coagulation-independent effects of thrombin and Factor Xa: role of protease-activated receptors in pulmonary hypertension.
Joseph C; Berghausen EM; Behringer A; Rauch B; Ten Freyhaus H; Gnatzy-Feik LL; Krause M; Wong DWL; Boor P; Baldus S; Vantler M; Rosenkranz S
Cardiovasc Res; 2022 Dec; 118(16):3225-3238. PubMed ID: 35104324
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of angiogenesis by small-molecule antagonists of protease-activated receptor-1.
Tsopanoglou NE; Maragoudakis ME
Semin Thromb Hemost; 2007 Oct; 33(7):680-7. PubMed ID: 18000795
[TBL] [Abstract][Full Text] [Related]
26. Protease-activated receptor signaling: new roles and regulatory mechanisms.
Traynelis SF; Trejo J
Curr Opin Hematol; 2007 May; 14(3):230-5. PubMed ID: 17414212
[TBL] [Abstract][Full Text] [Related]
27. Tissue factor mediates inflammation.
Chu AJ
Arch Biochem Biophys; 2005 Aug; 440(2):123-32. PubMed ID: 16036212
[TBL] [Abstract][Full Text] [Related]
28. Role of coagulation factor Xa and protease-activated receptor 2 in human mesangial cell proliferation.
Tanaka M; Arai H; Liu N; Nogaki F; Nomura K; Kasuno K; Oida E; Kita T; Ono T
Kidney Int; 2005 Jun; 67(6):2123-33. PubMed ID: 15882255
[TBL] [Abstract][Full Text] [Related]
29. Regulation of angiogenesis by tissue factor cytoplasmic domain signaling.
Belting M; Dorrell MI; Sandgren S; Aguilar E; Ahamed J; Dorfleutner A; Carmeliet P; Mueller BM; Friedlander M; Ruf W
Nat Med; 2004 May; 10(5):502-9. PubMed ID: 15098027
[TBL] [Abstract][Full Text] [Related]
30. FXa-induced responses in vascular wall cells are PAR-mediated and inhibited by ZK-807834.
McLean K; Schirm S; Johns A; Morser J; Light DR
Thromb Res; 2001 Aug; 103(4):281-97. PubMed ID: 11562339
[TBL] [Abstract][Full Text] [Related]
31. Flow perturbation is linked to endothelial par signaling.
Ruf W
Arterioscler Thromb Vasc Biol; 2006 May; 26(5):962-4. PubMed ID: 16627820
[No Abstract] [Full Text] [Related]
32. Nonhemostatic Activities of Factor Xa: Are There Pleiotropic Effects of Anti-FXa Direct Oral Anticoagulants?
Papadaki S; Tselepis AD
Angiology; 2019 Nov; 70(10):896-907. PubMed ID: 31010298
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.
Jennings LK
Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875
[TBL] [Abstract][Full Text] [Related]
34. Overview of the postulated mechanisms linking cancer and thrombosis.
ten Cate H; Falanga A
Pathophysiol Haemost Thromb; 2008; 36(3-4):122-30. PubMed ID: 19176985
[TBL] [Abstract][Full Text] [Related]
35. Differential contribution of FXa and thrombin to vascular inflammation in a mouse model of sickle cell disease.
Sparkenbaugh EM; Chantrathammachart P; Mickelson J; van Ryn J; Hebbel RP; Monroe DM; Mackman N; Key NS; Pawlinski R
Blood; 2014 Mar; 123(11):1747-56. PubMed ID: 24449213
[TBL] [Abstract][Full Text] [Related]
36. Pleiotropic effects of factor Xa and thrombin: what to expect from novel anticoagulants.
Spronk HM; de Jong AM; Crijns HJ; Schotten U; Van Gelder IC; Ten Cate H
Cardiovasc Res; 2014 Mar; 101(3):344-51. PubMed ID: 24385341
[TBL] [Abstract][Full Text] [Related]
37. Generation of potent coagulation protease inhibitors utilizing zinc-mediated chelation.
Young WB; Sprengeler P; Shrader WD; Li Y; Rai R; Verner E; Jenkins T; Fatheree P; Kolesnikov A; Janc JW; Cregar L; Elrod K; Katz B
Bioorg Med Chem Lett; 2006 Feb; 16(3):710-3. PubMed ID: 16257204
[TBL] [Abstract][Full Text] [Related]
38. PAR1 signaling: more good than harm?
Ruf W
Nat Med; 2003 Mar; 9(3):258-60. PubMed ID: 12612568
[No Abstract] [Full Text] [Related]
39. Non-hemostatic activity of coagulation factor Xa: potential implications for various diseases.
Leadley RJ; Chi L; Porcari AR
Curr Opin Pharmacol; 2001 Apr; 1(2):169-75. PubMed ID: 11714092
[TBL] [Abstract][Full Text] [Related]
40. Roles of Coagulation Proteases and PARs (Protease-Activated Receptors) in Mouse Models of Inflammatory Diseases.
Posma JJ; Grover SP; Hisada Y; Owens AP; Antoniak S; Spronk HM; Mackman N
Arterioscler Thromb Vasc Biol; 2019 Jan; 39(1):13-24. PubMed ID: 30580574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
